Britain's inflation rate looks set to hit 4% in September in data due for release on Wednesday, the highest among the world's ...

Brunel University of London provides funding as a member of The Conversation UK. The UK’s science minister, Sir Patrick Vallance, has sounded the alarm over the country’s declining investment in ...

UK house prices rose more than expected in September, despite concerns about affordability as mortgage rates edged higher in recent weeks. The average cost of a home climbed 0.5% month-on-month, ...

Average UK house prices fell 0.3% in September, with the £794 decrease erasing gains in August and bringing the cost of a typical home to £298,184. Annually, prices grew 1.3% in September – the lowest ...

UK house prices rose by 0.5 per cent in September compared with the previous month, according to Nationwide, reversing a 0.1 per cent decline recorded in August. On an annual basis, property values ...

The bank said a relatively lower mortgage rate environment and steady wage growth have helped support buyer confidence. The average UK house price fell by £794 or 0.3 per cent month-on-month in ...

Pressure from Donald Trump to hike UK drug prices could wipe billions from the NHS budget, causing suffering to the “vast majority of NHS patients”, experts have warned. Health think tank, the ...

UK inflation remained at 3.8% in September for the third consecutive month in a shock reading after forecasters expected it to jump to 4%. While the inflation data came in better than many ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

Simply sign up to the UK inflation myFT Digest -- delivered directly to your inbox. UK shop price inflation in September rose to the highest rate since the spring of last year as high beef and dairy ...

Sept 29 (Reuters) - AbbVie (ABBV.N), opens new tab said on Monday it would launch its ovarian cancer drug Elahere in the UK at a list price matching that in the U.S. President Donald Trump has been ...

(Reuters) -AbbVie said on Monday it would launch its ovarian cancer drug Elahere in the UK at a list price matching that in the U.S. President Donald Trump has been demanding that drugmakers align ...